Market closedNon-fractional

KemPharm/ZVRA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About KemPharm

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Ticker

ZVRA

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Celebration, United States

Employees

67
Website
zevra.com

KemPharm Metrics

BasicAdvanced
$265M
Market cap
-
P/E ratio
-$1.33
EPS
1.87
Beta
-
Dividend rate
$265M
1.87
2.103
2.04
89.522
90.717
-27.88%
-27.75%
-82.27%
8.53
5.42
-11.21
-5.147
195.67%
-11.10%
5.92%
-42.09%

What the Analysts think about KemPharm

Analyst Ratings

Majority rating from 6 analysts.
Buy

KemPharm Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-488.23% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.4M
-74.24%
Net income
-$17M
9.93%
Profit margin
-488.23%
326.81%

KemPharm Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 16.32%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.15
-$0.40
-$0.40
-$0.40
-
Expected
-$0.34
-$0.30
-$0.27
-$0.48
-$0.42
Surprise
-56.31%
34.45%
49.07%
-16.32%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for KemPharm stock?

KemPharm (ZVRA) has a market cap of $265M as of July 23, 2024.

What is the P/E ratio for KemPharm stock?

The price to earnings (P/E) ratio for KemPharm (ZVRA) stock is 0 as of July 23, 2024.

Does KemPharm stock pay dividends?

No, KemPharm (ZVRA) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next KemPharm dividend payment date?

KemPharm (ZVRA) stock does not pay dividends to its shareholders.

What is the beta indicator for KemPharm?

KemPharm (ZVRA) has a beta rating of 1.87. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell KemPharm stock

Buy or sell KemPharm stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing